Look for New GLP-1 Agonist and Flozin Options for Type 2 Diabetes

February 2018

You'll see more players join the crowded field of type 2 diabetes meds...Bydureon BCise, Ozempic (oh-ZEM-pik), Steglatro (steh-GLAH-troh).

Bydureon BCise (exenatide ER) and Ozempic (semaglutide) will bring the total to eight GLP-1 agonists. Both are once-WEEKLY injections.

Bydureon BCise is extended-release exenatide, like Bydureon. You'll hear it gives more consistent drug levels in a simpler pen device.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote